The Anticoagulants Market report offers insights into the latest trends. It summarizes key aspects of the market, with focus on leading key players, areas that have witnessed the highest demand, leading regions, and applications.

The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share and Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026.

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anticoagulants-market-101807

Leading Players operating in the Anticoagulants Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Bayer AG
  • Janssen Pharmaceuticals, Inc.
  • Eisai Co., Ltd

Increasing Number of Company Mergers Will Aid Market Growth

Several growth stimulating factors have been analyzed and discussed in detail. Among all factors, the increasing number of company mergers have had the highest impact on the market. In February 2019, Novartis AG and Blackstone’s LifeSciences announced the launch of Anthos Therapeutics. The company is aiming for the research and development of drugs that include anticoagulants as a prime pipeline candidate. Increasing number of drug approvals is another factor that has constituted an increase in the global anticoagulants market size in recent years. Janssen Pharmaceuticals’ Rivaroxaban is an example of a recent drug approval that has had a direct impact on the market.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/anticoagulants-market-101807

Detailed Table of Content:

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Prevalence of Major Cardiovascular Diseases by Key Countries
    • Overview of Novel Oral Anticoagulants (NOACs)
    • Pipeline Analysis
    • Key Industry Developments Such as Mergers and Acquisitions
    • New Product Launches
    • Regulatory Scenario in Key Countries
    • Reimbursement Scenario by Key Countries
  5. Global Anticoagulants Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Disease Indication
      • Pulmonary Embolism (PE)
      • Deep Vein Thrombosis (DVT)
      • Atrial Fibrillation
      • Heart Attacks
      • Others
    • Market Analysis, Insights and Forecast By Route of Administration
      • Oral
      • Injectable
    • Market Analysis, Insights and Forecast By Distribution Channel
      • Hospitals Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Market Analysis, Insights and Forecast By Country
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East and Africa

TOC Continued….

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anticoagulants-market-101807

Market Segmentation:

By Disease Indication

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Atrial Fibrillation
  • Heart Attacks
  • Others

By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)

More Trending Topics from Fortune Business Insights:

Sharps Containers Market Is Expected to Reach USD 624.1 Million by 2026; Rising Need for Effective Waste Management Will Encourage Growth, says Fortune Business Insights

Aesthetic Implants Market to reach USD 6.14 Billion by 2026, exhibiting a CAGR of 6.6% | Fortune Business Insights

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin|Twitter|BLogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Anticoagulants Market Business Advancements, Technological Strategies, Growth, Share and Top-Vendor Landscape Forecast to 2026